Additional file 2: of Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA
Leihong Wu
Taylor Ingle
Zhichao Liu
Anna Zhao-Wong
Stephen Harris
Shraddha Thakkar
Guangxu Zhou
Junshuang Yang
Joshua Xu
Darshan Mehta
Weigong Ge
Weida Tong
Hong Fang
10.6084/m9.figshare.7850462.v1
https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Study_of_serious_adverse_drug_reactions_using_FDA-approved_drug_labeling_and_MedDRA/7850462
Table S2. Drugs and PT distributions among MedDRA SOCs (XLS 33 kb)
2019-03-14 05:00:00
Adverse drug reactions
Data mining
MedDRA
Drug labeling
Boxed Warning
Structured product labeling
Standard terminology
Drug safety